In pretreated tumor samples, IHC results showed that patients with high levels of GC had lower numbers of tumor infiltrating CD3+ (p=0.001), CD8+ (p=0.059), and CD4+ (p=0.002) cells compared to those with low levels of GC (Figures 7A, B). This evidence concerns the gene CD8A and neoplasm.